Early Lung Cancer Detection Using Computed Tomography

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by University Health Network, Toronto.
Recruitment status was  Recruiting
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
First received: September 12, 2005
Last updated: February 2, 2012
Last verified: February 2012

Early detection of lung cancer may improve treatment outcomes. Risk factors have been identified, suggesting a population which might benefit from regular screening. Lung cancer screening using low-dose computed tomography (LDCT) has experienced a recent renaissance with reported sensitivity for detection of lung cancer of 2.7% in high-risk populations. The purpose of this study is to evaluate the utility of LCDT for the early diagnosis of lung cancer in Ontario.

Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lung Cancer Screening in High-risk Smokers Using Low-dose Computed Tomography

Resource links provided by NLM:

Further study details as provided by University Health Network, Toronto:

Estimated Enrollment: 5000
Study Start Date: September 2003

Ages Eligible for Study:   55 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

high risk current and former smokers


Inclusion Criteria:

55 years or older at least 10 pack-year history of smoking general good health

Exclusion Criteria:

any prior cancers except non-melanotic skin cancer

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188734

Contact: Heidi C Roberts, MD 416-340-4800 ext 3375 Heidi.Roberts@uhn.on.ca
Contact: Maureen McGregor 416-946-4501 ext 6318 Maureen.mcgregor@uhn.on.ca

Canada, Ontario
Princess Margaret Hospital Recruiting
Toronto, Ontario, Canada
Contact: Heidi C Roberts, MD    416-340-4800 ext 3375    Heidi.roberts@uhn.on.ca   
Contact: Maureen McGregor    416-946-4501 ext 6318    Maureen.mcgregor@uhn.on.ca   
Principal Investigator: Heidi C Roberts, MD         
Sponsors and Collaborators
University Health Network, Toronto
Principal Investigator: Heidi C Roberts, MD University Health Network, Toronto
  More Information

Additional Information:
No publications provided

Responsible Party: UHN Toronto
ClinicalTrials.gov Identifier: NCT00188734     History of Changes
Other Study ID Numbers: I-ELCAP
Study First Received: September 12, 2005
Last Updated: February 2, 2012
Health Authority: Canada: Health Canada

Keywords provided by University Health Network, Toronto:
Lung Cancer
Eary Diagnosis

Additional relevant MeSH terms:
Lung Neoplasms
Lung Diseases
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms

ClinicalTrials.gov processed this record on May 21, 2015